Accelerate Diagnostics Inc (AXDX) Gross Profit Margin starting from the fourth quarter 2024 to fourth quarter 2023, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Accelerate Diagnostics Inc   (NASDAQ: AXDX)


Accelerate Diagnostics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



AXDX Gross Profit Margin (Dec 31 2024)
Q4
(Sep 30 2024)
Q3
(Jun 30 2024)
Q2
(Mar 31 2024)
Q1
(Dec 31 2023)
Q4
Y / Y Revenue Change -6.97 %
Seq. Revenue Change -1.4 %
Revenue In Millions $2.82
Gross Profit Margin 15.94 %
Gross Profit Margin Total Ranking # 3491
Gross Profit In Millions $0.45
Y / Y Gross Profit Change -29.07 %
Seq. Gross Profit Change -47.55 %


Commenting fourth quarter 2024 Gross Profit Margin
Accelerate Diagnostics Inc experienced contraction in Gross Profit by -47.55 % to $3 millions and Revenue by -1.4 %, while Gross Profit Margin fell to 15.94 %, below company*s average Gross Profit Margin.


Observing fourth quarter 2024 results within Laboratory Analytical Instruments industry 25 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 2716 to 3491.
Learn about Gross Margin
AXDX's Gross Profit Margin fourth quarter 2024 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 26
Healthcare Sector # 483
Overall # 3455

Gross Profit Margin Statistics
High Average Low
95.09 % 41.53 % 9.67 %
(Mar 31 2017)   (Sep 30 2023)




Other Gross Profit Margin Profitability Ratios
AXDX's Cumulative Gross Profit Margin
Laboratory Analytical Instruments Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
AXDX's Gross Profit Margin Profitability versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for AXDX's Competitors
Gross Profit Margin Profit Margin for Accelerate Diagnostics Inc 's Suppliers
Gross Profit Margin Profit Margin for AXDX's Customers

You may also want to know
AXDX's Annual Growth Rates AXDX's Profitability Ratios AXDX's Asset Turnover Ratio AXDX's Dividend Growth
AXDX's Roe AXDX's Valuation Ratios AXDX's Financial Strength Ratios AXDX's Gross Profit Growth
AXDX's Roa AXDX's Inventory Turnover Ratio AXDX's Growth Rates AXDX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2024, within Laboratory Analytical Instruments Industry Gross Profit MarginDec 31 2024 MRQ Gross ProfitDec 31 2024 MRQ Revenue
Bionano Genomics Inc   41.86 %$ 3.417  Millions$ 8.163  Millions
Seer Inc   40.30 %$ 2.025  Millions$ 5.025  Millions
Lifeloc Technologies Inc   36.92 %$ 0.705  Millions$ 1.910  Millions
Scientific Industries Inc   36.88 %$ 1.037  Millions$ 2.813  Millions
Avantor Inc   33.37 %$ 562.900  Millions$ 1,686.600  Millions
Rapid Micro Biosystems Inc   31.41 %$ 2.581  Millions$ 8.218  Millions
Kewaunee Scientific Corporation  27.69 %$ 18.379  Millions$ 66.379  Millions
Pacific Biosciences Of California Inc   25.11 %$ 10.058  Millions$ 40.058  Millions
Accelerate Diagnostics Inc   15.94 %$ 0.449  Millions$ 2.816  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.